Calrecia 100 mmol/l Solution à diluer pour perfusion
Country: Switzerland
Language: French
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Patient Information leaflet
(PIL)
16-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
calcii chloridum dihydricum
Available from:
Fresenius Medical Care (Schweiz) AG
ATC code:
B05XA07
INN (International Name):
calcii chloridum dihydricum
Pharmaceutical form:
Solution à diluer pour perfusion
Composition:
calcii chloridum dihydricum 14.7 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml corresp. calcium 100 mmol/l, chloridum 200 mmol/l.
Class:
B
Therapeutic group:
Synthetika
Therapeutic area:
Calrecia wird angewendet zur Calciumsubstitution bei kontinuierlicher Nierenersatztherapie (CRRT), langsamer verlängerter (täglicher) Dialyse (SLEDD) und therapeutischem Plasmaaustausch (TPE) mit Citratantikoagulation.
Authorization status:
zugelassen
Authorization date:
2023-03-24
